Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Commercial Truck Driver Health and Safety-Preventing Injury and Illness, Request for Applications (RFA) 07-001, 53104 [E6-14863]

Download as PDF 53104 Federal Register / Vol. 71, No. 174 / Friday, September 8, 2006 / Notices toxicologic testing under TSCA or FIFRA. This part of the research will be conducted according to established TSCA/FIFRA procedures and guidelines. B. Private-Sector Voluntarism As part of the SSARP, on February 7, 1992, ATSDR announced a set of proposed procedures for conducting voluntary research (57 FR 4758). Revisions based on public comments were published on November 16, 1992 (57 FR 54160). ATSDR strongly encourages private-sector organizations to propose research to address priority data needs at any time until ATSDR announces that research has already been initiated for a specific priority data need. Private-sector organizations may volunteer to conduct research to address specific priority data needs identified in this notice by indicating their interest through submission of a letter of intent. The letter of intent should be a brief statement (1–2 pages) that identifies the priority data need(s) to be filled and the methods to be used. The Tri-Agency Superfund Applied Research Committee (TASARC) will review these proposals and make recommendations to ATSDR regarding which specific voluntary research projects should be pursued— and how they should be conducted— with the volunteer organizations. ATSDR will enter into only those voluntary research projects that lead to high quality, peer-reviewed scientific work. Additional details regarding the process for voluntary research are in the Federal Register notices cited in this section. C. CERCLA Those priority data needs that are not addressed by TSCA/FIFRA or initial voluntarism will be considered for funding by ATSDR through its CERCLA budget. A large part of this research program is envisioned to be unique to CERCLA—for example, research on substances not regulated by other programs or research needs specific to public health assessments. A current example of the direct use of CERCLA funds is a cooperative agreement with the Minority Health Professions Foundation (MHPF) that supports the MHPF’s Environmental Health, Health Services and Toxicology Research Program. Mechanisms to address these priority data needs may include a second call for voluntarism. Again, scientific peer review of study protocols and results would occur for all research conducted under this auspice. Substance-Specific Priority Data Needs The priority data needs are identified in Table 1. Specifically, for acrolein, three priority data needs have been identified, while one priority data need was identified for barium. ATSDR encourages private-sector organizations and other governmental programs to use ATSDR’s priority data needs to plan their research activities. Dated: September 1, 2006. Kenneth Rose, Acting Director, Office of Policy, Planning, and Evaluation, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry. TABLE 1.—SUBSTANCE-SPECIFIC PRIORITY DATA NEEDS (PDN) FOR FOURTH SET OF TWO PRIORITY HAZARDOUS SUBSTANCES Substance Acrolein ................................ Barium .................................. Priority data needs Exposure levels in humans living near hazardous waste sites. Exposure levels of children. Dose-response data for chronic-duration (1) via inhalation exposure. Dose-response data for acute-duration (2) via oral exposure. (1) 365 days or more. (2) 14 days or less. [FR Doc. E6–14870 Filed 9–7–06; 8:45 am] BILLING CODE 4163–70–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sroberts on PROD1PC70 with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Commercial Truck Driver Health and Safety—Preventing Injury and Illness, Request for Applications (RFA) 07–001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Commercial Truck Driver Health and Safety—Preventing Injury and Illness, RFA 07–001. VerDate Aug<31>2005 19:38 Sep 07, 2006 Jkt 208001 Times and Dates: 7 p.m.–9 p.m., October 11, 2006 (Closed). 8 a.m.–5 p.m., October 12, 2006 (Closed). Place: Embassy Suites, 1900 Diagonal Road, Alexandria, VA 20036, telephone (703) 684–5900. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of research grant applications in response to RFA 07–001, ‘‘Commercial Truck Driver Health and Safety—Preventing Injury and Illness.’’ Contact Person for More Information: George Bokosh, Designated Federal Officer, 626 Cochrans Mill Road, Pittsburgh, PA 15236, telephone (412) 386–6465. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 Dated: August 31, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–14863 Filed 9–7–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Prospective Grant of Exclusive License: Insecticide-Impregnated Bednet Technology Transfer Office, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. ACTION: Notice. AGENCY: SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the Centers for Disease E:\FR\FM\08SEN1.SGM 08SEN1

Agencies

[Federal Register Volume 71, Number 174 (Friday, September 8, 2006)]
[Notices]
[Page 53104]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-14863]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Commercial Truck Driver Health and Safety--Preventing 
Injury and Illness, Request for Applications (RFA) 07-001

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Commercial Truck Driver Health and 
Safety--Preventing Injury and Illness, RFA 07-001.
    Times and Dates: 7 p.m.-9 p.m., October 11, 2006 (Closed).
    8 a.m.-5 p.m., October 12, 2006 (Closed).
    Place: Embassy Suites, 1900 Diagonal Road, Alexandria, VA 20036, 
telephone (703) 684-5900.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of research grant applications in 
response to RFA 07-001, ``Commercial Truck Driver Health and 
Safety--Preventing Injury and Illness.''
    Contact Person for More Information: George Bokosh, Designated 
Federal Officer, 626 Cochrans Mill Road, Pittsburgh, PA 15236, 
telephone (412) 386-6465.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: August 31, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-14863 Filed 9-7-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.